Lonza Group AG
Research Lonza Group AG (LONN) on Bullrun: market cap CHF 37.69B, P/E 41.5, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLONN
- ExchangeSW
- CountrySwitzerland
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyCHF
- Market capCHF 37.69B
- P/E41.5
- Dividend yield0.9%
- Financial periodFY2025
- RevenueCHF 6.53B
- Revenue growth19.2%
- Net income-CHF 275.00M
- Free cash flow-CHF 217.00M
- Gross margin35.4%
Valuation Snapshot
latest market cap is CHF 37.69B; P/E is 41.5; dividend yield is 0.9%.
About Lonza Group AG
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing;
Frequently asked questions
What is Lonza Group AG's market cap?
Lonza Group AG's market capitalization is CHF 37.69B.
What is Lonza Group AG's P/E ratio?
Lonza Group AG's price-to-earnings (P/E) ratio is 41.5.
Does Lonza Group AG pay a dividend?
Lonza Group AG has a dividend yield of 0.9%.
What does Lonza Group AG do?
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics;